July 21, 2020
The Japan Pharmaceutical Association (JPA) expressed strong discomfort on July 17 against the government’s plan confirmed in its annual policy blueprint to conduct a drug price survey this year for “off-year” re-pricing scheduled for FY2021 despite the COVID-19 crisis. The...read more